Nicholas A Meanwell, Makonen Belema, David J Carini, Stanley V D'Andrea, John F Kadow, Mark Krystal, B Narasimhulu Naidu, Alicia Regueiro-Ren, Paul M Scola, Sing-Yuen Sit, Michael A Walker, Tao Wang, Kap-Sun Yeung
{"title":"Developments in antiviral drug design, discovery and development in 2004.","authors":"Nicholas A Meanwell, Makonen Belema, David J Carini, Stanley V D'Andrea, John F Kadow, Mark Krystal, B Narasimhulu Naidu, Alicia Regueiro-Ren, Paul M Scola, Sing-Yuen Sit, Michael A Walker, Tao Wang, Kap-Sun Yeung","doi":"10.2174/156800505774912893","DOIUrl":null,"url":null,"abstract":"<p><p>This article summarizes key aspects of progress made during 2004 toward the design, discovery and development of antiviral agents for clinical use. Important developments in the identification, characterization and clinical utility of inhibitors of human immunodeficiency virus; the hepatitis viruses, hepatitis B, hepatitis C; the herpes family of viruses, herpes simplex viruses 1 and 2, varicella zoster virus, Epstein-Barr virus and human cytomegalovirus; the respiratory viruses, influenza, respiratory syncytial virus, human metapneumovirus, picornaviruses, measles and the severe acute respiratory syndrome coronavirus; human papilloma virus; rotavirus; Ebola virus and West Nile virus, are reviewed.</p>","PeriodicalId":84525,"journal":{"name":"Current drug targets. Infectious disorders","volume":"5 4","pages":"307-400"},"PeriodicalIF":0.0000,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/156800505774912893","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets. Infectious disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/156800505774912893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
This article summarizes key aspects of progress made during 2004 toward the design, discovery and development of antiviral agents for clinical use. Important developments in the identification, characterization and clinical utility of inhibitors of human immunodeficiency virus; the hepatitis viruses, hepatitis B, hepatitis C; the herpes family of viruses, herpes simplex viruses 1 and 2, varicella zoster virus, Epstein-Barr virus and human cytomegalovirus; the respiratory viruses, influenza, respiratory syncytial virus, human metapneumovirus, picornaviruses, measles and the severe acute respiratory syndrome coronavirus; human papilloma virus; rotavirus; Ebola virus and West Nile virus, are reviewed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
